Furthermore, the association of selumetinib with ABT-263, a BH3-mimetic that disrupts the interactions of Bcl-2 and Bcl-XL with pro-apoptotic proteins (145), also induced caspase-dependent cell death in A375 melanoma cell line (146). This evidence concerns the gene BCL2 and melanoma.